ForSight Labs

ForSight Labs

Innovative solutions enhancing vision and quality of life for visually impaired patients through collaboration and advanced technology.

Founded 2005 Debt Financing Total: $69.40M Biotechnology, Health Care

ForSight Labs is a biotechnology and healthcare startup founded in 2005, with a clear mission encapsulated in their slogan: "Innovative solutions enhancing vision and quality of life for visually impaired patients through collaboration and advanced technology." The company is dedicated to creating and implementing solutions that enhance the vision, care, and quality of life for visually impaired individuals, operating within high-impact eye care companies. Every day, countless individuals depend on their vision and endure significant hardships when it is compromised. Vision loss drastically affects the quality of life, making it one of the most impactful disabilities. In the US, the number of people experiencing vision impairment, including blindness, is projected to more than double in the next three decades, with the annual cost of vision loss in the US recently estimated to exceed $50 billion. ForSight Labs unites highly driven and capable team members, clinicians, and investors with a shared focus on initiating and sustaining efforts to provide innovative solutions to the ophthalmic community and the patients it serves. Last investment: $1.70M Debt Financing investment at 04 September 2015. The investors for this round are not specified. In summary, ForSight Labs is a forward-thinking startup addressing a substantial need in the healthcare and biotechnology industries through innovative and impactful solutions for visually impaired patients. With a clear focus and a track record of attracting significant investments, ForSight Labs demonstrates potential for growth and impact in the coming years.

Funding Stage	Amount	Investors	Lead Investors	Date
Debt Financing	$1.70M	-		04 Sep 2015
Venture Round	$3.00M	-		08 Dec 2014
Venture Round	$1.00M	-		06 May 2014
Series C	$15.00M	4	H.I.G. BioHealth Partners, Technology Partners +2	16 Apr 2014
Series B	$9.30M	4	Technology Partners, Morgenthaler Ventures +2	17 Jun 2013
Venture Round	$8.00M	-		17 Aug 2012
Venture Round	$6.00M	-		08 Feb 2011
Venture Round	$6.00M	-		10 Aug 2009
Venture Round	$12.00M	-		12 May 2009
Series A	$5.00M	3	Morgenthaler Ventures, Versant Ventures +1	03 Apr 2007

Funding Stage

Amount

Investors

Lead Investors

Date

Debt Financing

$1.70M

04 Sep 2015

Venture Round

$3.00M

08 Dec 2014

Venture Round

$1.00M

06 May 2014

Series C

$15.00M

H.I.G. BioHealth Partners, Technology Partners +2

16 Apr 2014

Series B

$9.30M

Technology Partners, Morgenthaler Ventures +2

17 Jun 2013

Venture Round

$8.00M

17 Aug 2012

Venture Round

$6.00M

08 Feb 2011

Venture Round

$6.00M

10 Aug 2009

Venture Round

$12.00M

12 May 2009

Series A

$5.00M

Morgenthaler Ventures, Versant Ventures +1

03 Apr 2007

FAQ About ForSight Labs

Innovative solutions enhancing vision and quality of life for visually impaired patients through collaboration and advanced technology.

ForSight Labs was founded in 2005.

ForSight Labs operates in Biotechnology and Health Care. Its work centres on vision enhancement, visually impaired, innovative technology and ophthalmic solutions.

ForSight Labs has completed 11 funding rounds, raising a total of $69.40M. The latest funding stage is Debt Financing.

Top alternatives and competitors to ForSight Labs include Refocus Group, LENTECHS, Visiox Pharmaceuticals, Zedsen, Accelera Innovations. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

ForSight Labs and Refocus Group are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About ForSight Labs

Funding Rounds & Investors (11)

ForSight Labs Alternatives & Competitors

FAQ About ForSight Labs